Ciproxifan maleate (FUB 359 maleate) is a potent, selective, orally bioavailable and competitive antagonist of histamine H3-receptor, with an IC50 of 9.2 nM. Ciproxifan maleate displays low apparent affinity at other receptor subtypes. Ciproxifan maleate can be used for the research of aging disorders and Alzheimer's disease.
Histamine Receptor Inhibitors Related Products:
Pitolisant; Pitolisant oxalate; Loratadine; Bepotastine; Ciproxifan; Fexofenadine hydrochloride; Hydroxyzine dihydrochloride; Azatadine maleate; Betahistine dihydrochloride; Ebastine; Pitolisant hydrochloride